Root Financial Partners’s Nuvectis Pharma NVCT Stock Holding History

Root Financial Partners’s Portfolio NVCT Stock Details NVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$148	Buy	+7	New	+$148	﹤0.01%	3577

Other funds holding NVCT

Baldwin Wealth Partners Marion, Massachusetts $1.52B AUM 21.45% 1-Year Est. Return

J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Root Financial Partners's NVCT Position: Q3 2026 in Review

Root Financial Partners opened a new position in Nuvectis Pharma (NVCT) in Q3 2026: 7 shares worth $148. The stake represents ﹤0.01% of the portfolio and ranks #3577 among its holdings.

9 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.

Root Financial Partners held 7 shares of Nuvectis Pharma worth $148 as of Q3 2026.
Nuvectis Pharma was a new Root Financial Partners position in Q3 2026.
Nuvectis Pharma made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3577 holding.
9 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.